Therapeutic benefit of adjunctive dipyridamole in schizophrenia is probably due to adenosine-glutamate interactions

Authors: Brunstein, M. G.¹; Belmonte-de-Abreu, P.¹; Souza, D. O.²; Lara, D. R.²

Source: Journal of Clinical Pharmacy & Therapeutics, Volume 26, Number 2, April 2001 , pp. 155-156(2)

Publisher: Wiley-Blackwell

Document Type: Letter to the Editor

DOI: http://dx.doi.org/10.1046/j.1365-2710.2001.00335.x

Affiliations: 1: Department of Psychiatry, HCPA, Porto Alegre, Brazil 2: Department of Biochemistry, ICBS (UFRGS) and PUCRS, Porto Alegre, Brazil

Publication date: 2001-04-01

• In this: publication
• By this: publisher
• In this Subject: Pharmacology
• By this author: Brunstein, M. G. ;  Belmonte-de-Abreu, P. ;  Souza, D. O. ;  Lara, D. R.

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers